We are live on
!
Find out more
Voloridge Investment Management Portfolio holdings
AUM
$25B
1-Year Est. Return
28.08%
This Fund
S&P 500
This Quarter
Est. Return
+24.52%
1 Year Est. Return
+28.08%
3 Year Est. Return
+85.2%
5 Year Est. Return
+73.43%
10 Year Est. Return
+582.16%
AUM
$11.9B
AUM Growth
-$101M
(-0.84%)
Cap. Flow
-$1.72B
Cap. Flow
% of AUM
-14.47%
Top 10 Holdings %
Top 10 Hldgs %
16.8%
Holding
1,692
New
482
Increased
315
Reduced
482
Closed
413
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$242M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$187M |
| 3 |
AstraZeneca
AZN
|
+$163M |
| 4 |
Lockheed Martin
LMT
|
+$162M |
| 5 |
S&P Global
SPGI
|
+$125M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$234M |
| 2 |
Johnson & Johnson
JNJ
|
+$185M |
| 3 |
Mercado Libre
MELI
|
+$136M |
| 4 |
Procter & Gamble
PG
|
+$128M |
| 5 |
Shopify
SHOP
|
+$126M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.38% |
| 2 | Healthcare | 15.54% |
| 3 | Consumer Discretionary | 12.1% |
| 4 | Industrials | 11.12% |
| 5 | Communication Services | 10.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Bio-Rad Laboratories Class A
BIO
$9.66B
| $9.71M | 0.08% |
16,663
-25,008
| -60% | -$14.2M |
|
277
PACCAR
PCAR
$68.8B
| $9.71M | 0.08% |
+168,731
| New | +$9.91M |
|
|
SINA
278
DELISTED
Sina Corp
SINA
| $9.68M | 0.08% |
228,376
-1,313
| -0.6% | -$56.5K |
|
279
MetLife
MET
$61.9B
| $9.65M | 0.08% |
+205,489
| New | +$8.9M |
|
280
Expedia Group
EXPE
$39.4B
| $9.63M | 0.08% |
72,716
-94,825
| -57% | -$10.7M |
|
281
Micron Technology
MU
$1.07T
| $9.62M | 0.08% |
+127,944
| New | +$7.72M |
|
282
Conagra Brands
CAG
$7.39B
| $9.41M | 0.08% |
259,642
+192,374
| +286% | +$6.98M |
|
283
Vir Biotechnology
VIR
$1.52B
| $9.4M | 0.08% |
+351,125
| New | +$11.4M |
|
284
Atmos Energy
ATO
$28.7B
| $9.4M | 0.08% |
98,491
+80,850
| +458% | +$7.8M |
|
285
PBF Energy
PBF
$8.81B
| $9.31M | 0.08% |
1,311,476
-789,000
| -38% | -$5.14M |
|
286
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
| $9.23M | 0.08% |
79,612
-60,573
| -43% | -$6.86M |
|
|
BIG
287
DELISTED
Big Lots, Inc.
BIG
| $9.21M | 0.08% |
+214,537
| New | +$10.4M |
|
|
SGMO
288
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $9.19M | 0.08% |
+588,624
| New | +$6.9M |
|
|
PPD
289
DELISTED
PPD, Inc. Common Stock
PPD
| $9.18M | 0.08% |
268,297
+57,853
| +27% | +$2.02M |
|
|
ICPT
290
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $9.17M | 0.08% |
371,324
+56,485
| +18% | +$1.87M |
|
|
GTLS
291
DELISTED
Chart Industries
GTLS
| $9.16M | 0.08% |
77,773
-34,979
| -31% | -$3.38M |
|
292
Children's Place
PLCE
$53.4M
| $9.09M | 0.08% |
181,507
-168,181
| -48% | -$6.12M |
|
293
Gentex
GNTX
$4.99B
| $9.03M | 0.08% |
266,155
+127,573
| +92% | +$3.93M |
|
294
Cleveland-Cliffs
CLF
$6.93B
| $9M | 0.08% |
+618,249
| New | +$6.26M |
|
295
Copa Holdings
CPA
$6.17B
| $8.99M | 0.08% |
116,430
-43,835
| -27% | -$2.92M |
|
296
Armstrong World Industries
AWI
$7.68B
| $8.97M | 0.08% |
120,636
-26,121
| -18% | -$1.89M |
|
297
Capri Holdings
CPRI
$1.77B
| $8.94M | 0.08% |
212,852
-88,316
| -29% | -$2.7M |
|
298
KLA
KLAC
$274B
| $8.94M | 0.08% |
+345,210
| New | +$8.05M |
|
299
Five Below
FIVE
$13.4B
| $8.87M | 0.07% |
50,663
+32,858
| +185% | +$4.87M |
|
|
ALXN
300
DELISTED
Alexion Pharmaceuticals
ALXN
| $8.87M | 0.07% |
56,737
-15,331
| -21% | -$1.97M |
|
Similar funds
VAI
JG
Voloridge Investment Management's Q4 2020 Portfolio in Review
As of Q4 2020, Voloridge Investment Management held 1,692 positions worth $11.9B, down 0.84% from $12B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Voloridge Investment Management withdrew a net $1.72B in Q4 2020, closing 413 positions and reducing 482 holdings. Its most notable exit was Wells Fargo, an estimated $111M position sold in full.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Voloridge Investment Management opened a new position in AstraZeneca worth $154M.
- Voloridge Investment Management's largest Q4 2020 buy was AstraZeneca: 1,542,881 shares worth $154M.
- Voloridge Investment Management added most to Microsoft in Q4 2020, an estimated $242M increase.
- Voloridge Investment Management's biggest Q4 2020 reduction was Citigroup, cutting an estimated $234M.
- Voloridge Investment Management fully exited Wells Fargo in Q4 2020, selling an estimated $111M.
- Voloridge Investment Management's ten largest holdings make up 17% of its $11.9B portfolio in Q4 2020.
- Voloridge Investment Management opened 482 new positions and closed 413 in Q4 2020.
- Voloridge Investment Management's portfolio value fell 0.84% quarter-over-quarter to $11.9B.
Based on Voloridge Investment Management's 13F filing for Q4 2020, filed 16 Feb 2021.